Company Profile

R And D Systems Inc (AKA: Research and Diagnostic Systems, Inc)
Profile last edited on: 5/23/2007      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

614 Mc Kinley Place Ne
Minneapolis, MN 55413
   (612) 379-2956
Location: Multiple
Congr. District: 05
County: Hennepin

Public Profile

Now outgrown the BSIR size standrd of 500 employees, R&D Systems is a specialty manufacturer of biological products with two operating divisions: Biotechnology and Hematology. The Biotechnology Division serves the basic research, clinical research, and clinical diagnostic markets with cytokine-related products for cancer, development, endocrinology, immunology, neuroscience, proteases, and stem cell research. The Hematology Division ranks among the world's leading developers and manufacturers of hematology analyzer controls, calibrators, and kits for verifying linearity and reportable range. The firm provide products and services to a broad range of customers worldwide--from academic and government research institutions; biotechnology and pharmaceutical companies; as well as hospitals, reference laboratories, and blood banks that perform patient testing and monitoring for quality control. In July 2005, R&D Systems, Inc. announced its purchase of Fortron Bio Science, Inc. (Morrisville, NC) and BiosPacific, Inc. (Emeryville, CA). Fortron develops and manufactures monoclonal and polyclonal antibodies and purified antigens. BiosPacific is the primary distribution arm of Fortron, and is a leading OEM supplier of biological reagents to the worldwide clinical diagnostics market. Fortron and BiosPacific have operated this strategic partnership since 1992, combining Fortron's development and manufacturing excellence with BiosPacific's marketing and sales expertise. Fortron and BiosPacific have earned a reputation as suppliers of high quality reagents and have established themselves as key vendors to many of the leading manufacturers of in vitro diagnostic systems, used globally in both clinical laboratory and point-of-care testing for evidence of cancer, cardiovascular and infectious diseases, endocrine disorders, and drugs of abuse.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Over 50M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1999 2 NIH $784,723
Project Title: Monoclonal Antibodies To Hiv Co/Chemokine Receptors

Key People / Management

  Thomas E Oland -- President

  Monica L Tsang

Company News

There are no news available.